Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00450814 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Plasma Cell Myeloma
Refractory Plasma Cell Myeloma

Interventions

DRUG: Cyclophosphamide
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
OTHER: Pharmacological Study

Sponsor

Mayo Clinic

Collaborators

[object Object]